[Atypical clinical manifestations as a form of presentation in multiple sclerosis]. 2021

María Cecilia Pita, and Ricardo N Alonso, and Leila Cohen, and Orlando Garcea, and Berenice A Silva
Centro Universitario de Esclerosis Múltiple, Hospital General de Agudos Dr. J.M. Ramos Mejía, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.

The atypical clinical features in multiple sclerosis (MS) have been rarely reported and suggest the possibility of an alternative diagnosis. The aim was to describe the clinical and demographic characteristics of MS patients who debuted with atypical symptoms and to estimate the sensitivity, specificity and positive predictive value (PPV) for MS diagnosis. A retrospective analysis of clinical records was performed. The following data were recorded: patients with MS diagnosis according to current diagnostic criteria at the time of diagnosis, type of symptom at the onset, time to second relapse, presence of oligoclonal bands (OCB) in cerebrospinal fluid (CSF) and radiological red flags on MRI. A descriptive and inferential analysis was performed using the chi square test, and sensitivity, specificity and PPV were calculated. Six hundred two patients were diagnosed with MS, of which 22 (3.65%) had an atypical clinical presentation. 54.5% were women. The mean age was 29 years (SD ± 11.7). The most common atypical symptom was peripheral facial palsy (27%). The PPV for atypical onset was 6.14%; p < 0.001. Sensitivity and specificity of these symptoms to MS diagnosis were 3.65% and 19%, respectively. In our research, the presence of atypical symptoms at the onset of MS was very low. Other diseases must be excluded, taking into account their low sensitivity, specificity and PPV.

UI MeSH Term Description Entries
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D043025 Oligoclonal Bands Multiple protein bands serving as markers of specific ANTIBODIES and detected by ELECTROPHORESIS of CEREBROSPINAL FLUID or serum. The bands are most often seen during inflammatory or immune processes and are found in most patients with MULTIPLE SCLEROSIS. Immunoglobulins, Oligoclonal,Oligoclonal Band,Oligoclonal Immunoglobulin,Oligoclonal Immunoglobulins,Oligoclonal IgG,Oligoclonal IgM,Band, Oligoclonal,Bands, Oligoclonal,IgG, Oligoclonal,IgM, Oligoclonal,Immunoglobulin, Oligoclonal

Related Publications

María Cecilia Pita, and Ricardo N Alonso, and Leila Cohen, and Orlando Garcea, and Berenice A Silva
June 1999, Medicina clinica,
María Cecilia Pita, and Ricardo N Alonso, and Leila Cohen, and Orlando Garcea, and Berenice A Silva
January 2016, Journal francais d'ophtalmologie,
María Cecilia Pita, and Ricardo N Alonso, and Leila Cohen, and Orlando Garcea, and Berenice A Silva
January 1999, Revista de neurologia,
María Cecilia Pita, and Ricardo N Alonso, and Leila Cohen, and Orlando Garcea, and Berenice A Silva
November 2020, Multiple sclerosis and related disorders,
María Cecilia Pita, and Ricardo N Alonso, and Leila Cohen, and Orlando Garcea, and Berenice A Silva
April 2013, Neurologia (Barcelona, Spain),
María Cecilia Pita, and Ricardo N Alonso, and Leila Cohen, and Orlando Garcea, and Berenice A Silva
September 2013, Semergen,
María Cecilia Pita, and Ricardo N Alonso, and Leila Cohen, and Orlando Garcea, and Berenice A Silva
July 2022, Cureus,
María Cecilia Pita, and Ricardo N Alonso, and Leila Cohen, and Orlando Garcea, and Berenice A Silva
August 2014, Materia socio-medica,
María Cecilia Pita, and Ricardo N Alonso, and Leila Cohen, and Orlando Garcea, and Berenice A Silva
September 1966, Neurologia, neurochirurgia i psychiatria polska,
María Cecilia Pita, and Ricardo N Alonso, and Leila Cohen, and Orlando Garcea, and Berenice A Silva
February 2019, Multiple sclerosis (Houndmills, Basingstoke, England),
Copied contents to your clipboard!